Abstract
Psychiatric aspects of patients with Parkinsonism treated with L-dopa are described. These include acute psychosis in patients with or without previous psychiatric illness and worsening or improvement of pre-existing psychiatric conditions. Therapeutic management is discussed The relevance of these studies to the understanding of the psychiatric aspects of Parkinsonism in general is discussed.
MeSH terms
-
Affect
-
Aged
-
Antidepressive Agents / therapeutic use
-
Anxiety
-
Arousal
-
Barbiturates / therapeutic use
-
Cognition Disorders / chemically induced
-
Depression / chemically induced
-
Dihydroxyphenylalanine / administration & dosage
-
Dihydroxyphenylalanine / adverse effects*
-
Dihydroxyphenylalanine / therapeutic use
-
Drug Antagonism
-
Drug Interactions
-
Female
-
Hallucinations / chemically induced
-
Humans
-
Male
-
Middle Aged
-
Neurotic Disorders / chemically induced*
-
Parkinson Disease / complications
-
Parkinson Disease / drug therapy*
-
Psychoses, Substance-Induced / etiology*
-
Psychotherapy
-
Sleep
-
Tranquilizing Agents / therapeutic use
-
Vision, Ocular
Substances
-
Antidepressive Agents
-
Barbiturates
-
Tranquilizing Agents
-
Dihydroxyphenylalanine